Beta-hydroxybutyrate

Beta-hydroxybutyrate has been studied in 104 papers since 2014: 5 trials and 3 observational studies in people, 56 in animals, 8 in cells, 31 reviews; 41 in the past year. Its furthest trials in people are at phase 2. The newest paper, Nov 9, 2026: “The Role and Mechanisms of β-Hydroxybutyrate in Musculoskeletal Diseases”.

InterventionPhase 2

104 papers study it41 more mention it136 findingsUpdated

PubChemChEBI

Research on it is growing 9% faster than aging research as a whole: 14 papers in the latest year counted

More supplements

6 new papers in 30 daysSee all 145 papers on beta-hydroxybutyrate

At a glance

Beta-hydroxybutyrate extends fly lifespan and reduces senescence in mouse cells, with both results repeated by independent labs. A preprint reports shortened D. magna lifespan at 2.5–10 mM, and human-cell inflammation results point both ways. One group reports human results, including lower LDL cholesterol in a trial; some papers declare company ties.

136 findings in 73 papers from 2014 to 2026, 4 of them since April 2026

The findings reach people, from one lab or study; independent labs found the same change in cells, worms or flies and mice. 37 independent labs in 10 countries; 3 trials, none about aging, 1 with no results posted.

“Within the BHB group, fat mass decreased significantly (-2 kg; p < 0.05 vs. baseline)”
Effect of Exogenous Ketones as an Adjunct to Low-Calorie Diet on Metabolic MarkersNutrients2025doi:10.3390/nu17223582

9 of its findings point the other way.

Cells, worms or flies and mice: replicated by independent labs. Humans: a single group.
  • 37 independent labs in 10 countries
  • 9 findings against
  • 3 trials, none about aging, 1 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 12 of 114 findings with company ties
  • Human trial5
  • Humans3
  • Animals47
  • Model organisms9
  • Cells8

Studies in people

2 studies gave beta-hydroxybutyrate to people and measured what changed.

What changedDesignPeopleSource

up: Increases apolipoprotein C-IIp = 0.023

Randomized trial150 min18 peopleBothPatient cohortsFrontiers in nutrition, Feb 5, 2026

down: Decreases fat mass

down: Decreases LDL cholesterol

Randomized trialeight-week51 peoplemale, n = 20; female, n = 3134.6 ± 6.7 yearsAdults between the ages of 18 and 46 yearsNutrients, Nov 16, 2025

What did studies of beta-hydroxybutyrate find?

100

Studies of beta-hydroxybutyrate measured 100 outcomes, among them lifespan, cellular senescence and inflammation.

Lifespan

upin B. manjavacas2no changein D. magna1downin D. magna1upin flies1+2

6 studies
  1. Beta-hydroxybutyrate extends lifespan in yeast cells (dose-dependently).

    Cellsdose-dependently

  2. Beta-hydroxybutyrate extends lifespan in B. manjavacas (treatment with beta-hydroxybutyrate).

    Model organismstreatment with beta-hydroxybutyrate

  3. Beta-hydroxybutyrate extends lifespan in B. manjavacas.

    Model organisms

  4. Beta-hydroxybutyrate showed no clear effect on lifespan in D. magna (intermittent exposure administered for 20-day periods).

    Model organismsintermittent exposure administered for 20-day periods

  5. Beta-hydroxybutyrate shortens lifespan in D. magna.

    Model organisms2.5 – 10 mM

  6. Beta-hydroxybutyrate extends lifespan in worms (BHB supplied during adulthood).

    Model organismsBHB supplied during adulthood

  7. Beta-hydroxybutyrate extends lifespan in flies (unbanged flies) (marked extension, no numbers given).

    Model organismsunbanged fliesdietary supplementmales

Cellular senescence

downin mouse cells2downin reviews2downin human cells1downin rat cells1

6 studies
  1. Beta-hydroxybutyrate decreases cellular senescence in rat cells (osteoarthritis chondrocytes).

    Cellsosteoarthritis chondrocytes

  2. Beta-hydroxybutyrate decreases cellular senescence in human cells (H2O2-induced senescence in HK-2 cells).

    CellsH2O2-induced senescence in HK-2 cells

  3. Beta-hydroxybutyrate decreases cellular senescence in podocytes exposed to a diabetic milieu.

    Cellsin podocytes exposed to a diabetic milieupodocyte

  4. Beta-hydroxybutyrate inhibits cellular senescence (Stress-induced premature senescence and replicative senescence).

    ReviewStress-induced premature senescence and replicative senescencevasculature

  5. Beta-hydroxybutyrate prevents cellular senescence.

    Reviewendothelial cells

  6. Beta-hydroxybutyrate inhibits cellular senescence in mouse cells (stress-induced premature senescence and replicative senescence).

    Cellsstress-induced premature senescence and replicative senescencevascular cells

More on Cellular senescence

Inflammation

upin human cells2downin human cells2downin mice2downin mouse cells1+1

5 studies
  1. Beta-hydroxybutyrate inhibits inflammation in HFD-induced MASLD mice.

    Animalsin HFD-induced MASLD micehippocampus20-week

  2. Beta-hydroxybutyrate decreases inflammation in mice (exogenous administration).

    Animalsexogenous administrationliver

  3. Beta-hydroxybutyrate induces inflammation in human cells.

    Cells

  4. Beta-hydroxybutyrate inhibits inflammation in mouse cells (LPS-induced; primary mouse microglia and BMDMs).

    CellsLPS-induced; primary mouse microglia and BMDMsmicroglia

  5. Beta-hydroxybutyrate inhibits inflammation in human cells (LPS-induced; primary human microglia).

    CellsLPS-induced; primary human microgliamicroglia

  6. Beta-hydroxybutyrate inhibits inflammation.

    Review

  7. Beta-hydroxybutyrate increases inflammation in human cells (primary human microglia, astrocytes and neurons).

    Cellsprimary human microglia, astrocytes and neurons

  8. Beta-hydroxybutyrate decreases inflammation in human cells (LPS-stimulated primary human microglia).

    CellsLPS-stimulated primary human microgliamicroglia

More on Inflammation

Proteostasis

upin mouse cells1upin reviews1

2 studies
  1. Beta-hydroxybutyrate improves proteostasis in mouse cells.

    Cells

  2. Beta-hydroxybutyrate improves proteostasis.

    Review

More on Proteostasis

PI3K–AKT signaling

upin mice1downin rat cells1

2 studies
  1. Beta-hydroxybutyrate activates PI3K–AKT signaling in HFD-induced MASLD mice.

    Animalsin HFD-induced MASLD micehippocampus20-week

  2. Beta-hydroxybutyrate inhibits PI3K–AKT signaling in rat cells (osteoarthritis chondrocytes).

    Cellsosteoarthritis chondrocytes

More on PI3K–AKT signaling

Cognitive function

upin mice2

2 studies
  1. Beta-hydroxybutyrate improves cognitive function in HFD-induced MASLD mice.

    Animalsin HFD-induced MASLD mice20-week

  2. Beta-hydroxybutyrate improves cognitive function in aging mice.

    Animalsin aging mice

Fecundity

upin D. magna1no changein Daphnia1

2 studies
  1. Beta-hydroxybutyrate showed no clear effect on fecundity in Daphnia (fully fed diet).

    Model organismsfully fed diet

  2. Beta-hydroxybutyrate increases fecundity in D. magna.

    Model organisms

Oxidative stress and ROS signaling

downin mouse cells1downin reviews1

2 studies
  1. Beta-hydroxybutyrate decreases oxidative stress and ROS signaling.

    Review

  2. Beta-hydroxybutyrate decreases oxidative stress and ROS signaling in mouse cells (microglia).

    Cellsmicroglia

More on Oxidative stress and ROS signaling

Autophagy

upin mice1upin reviews1

2 studies
  1. Beta-hydroxybutyrate activates autophagy.

    Review

  2. Beta-hydroxybutyrate induces autophagy in mice.

    Animalsbrain

More on Autophagy

Infarct volume

no changein mice1downin mice1

1 study
  1. Beta-hydroxybutyrate showed no clear effect on infarct volume in mice (Treatment initiated 10 hours after MCAO).

    AnimalsTreatment initiated 10 hours after MCAObrain

  2. Beta-hydroxybutyrate decreases infarct volume in mice After MCAO.

    AnimalsAfter MCAObrain5 g·kg−1·d−1

Fat mass

downin humans1

1 study
  1. Beta-hydroxybutyrate decreases fat mass in humans.

    Human trialeight-weekn = 51

  2. Beta-hydroxybutyrate decreases fat mass in humans (adjunct to a hypocaloric diet) (-2 kg, p < 0.05 vs. baseline).

    Human trialadjunct to a hypocaloric diet8 weeksn = 51

Apolipoprotein C-II

upin humans1

1 study
  1. Beta-hydroxybutyrate increases apolipoprotein C-II in humans (p = 0.023).

    Human trialbeverage150 minn = 18

More on Apolipoprotein C-II

LDL cholesterol

downin humans1

1 study
  1. Beta-hydroxybutyrate decreases LDL cholesterol in humans.

    Human trialeight-weekn = 51

More on LDL cholesterol

All 100

What is beta-hydroxybutyrate linked with?

5

Studies link beta-hydroxybutyrate with 5 measures, among them MHC-II gene expression, myocardial infarction and colorectal cancer.

MHC-II gene expression

mixedin human cells1mixedin mice1

1 study
  1. Beta-hydroxybutyrate is associated with MHC-II gene expression in Raji cells.

    Cellsin Raji cells

  2. Beta-hydroxybutyrate is associated with MHC-II gene expression in mice.

    Animalsspleen

Myocardial infarction

upin silico1OR 1.407

1 study
  1. Beta-hydroxybutyrate raises the risk of myocardial infarction in silico (univariable Mendelian randomization (IVW)) (OR = 1.407, 95% CI: 1.1660-1.6980).

    In silicounivariable Mendelian randomization (IVW)

More on Myocardial infarction

Colorectal cancer

upin reviews1

1 study
  1. Beta-hydroxybutyrate raises the risk of colorectal cancer in cancer cells with mutations in APC, KRAS, and TP53.

    Reviewin cancer cells with mutations in APC, KRAS, and TP53

More on Colorectal cancer

Muscle recovery

upin reviews1

1 study
  1. Beta-hydroxybutyrate is associated with muscle recovery in muscle atrophy models.

    Reviewin muscle atrophy modelssupplementmuscle

Epigenetic regulation of gene expression

upin reviews1

1 study
  1. Beta-hydroxybutyrate is associated with epigenetic regulation of gene expression.

    Review

More on Epigenetic regulation of gene expression

Has beta-hydroxybutyrate been tested in people?

0 of 3 about aging

Yes: 5 trials and 3 observational studies in people have been published, and 3 trials are registered.

Latest change Phase 1 → Phase 2Nov 13, 2026

In trials

Trial sponsors

Funding

5 grants since 2020

National Institute on Aging$9MNational Heart, Lung, and Blood Institute$742KNatural Science Foundation of Guangdong ProvinceCN¥100K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A cell study finds beta-hydroxybutyrate extends yeast lifespan; another reports reduced inflammation in LPS-treated mouse and human cells. A mouse study shows reduced CD8+ T-cell dysfunction and improved CAR T-cell antitumor activity in aged microenvironments; a preprint reports mTOR inhibition in aged mouse splenocytes.

  2. Summary written from the findings.

Latest

Dec 2025: 7Jan 2026: 4Feb 2026: 10Mar 2026: 9Apr 2026: 1May 2026: 3Jun 2026: 2Jul 2026: 2Aug 2026: 1Sep 2026: 6Oct 2026: 3Nov 2026: 250 papers in 12 months

See all 145 papers on beta-hydroxybutyrate